Ahammune Biosciences

Innovating Skin Therapeutics for Global Impact

Ahammune Biosciences is reimagining therapeutic solutions to address autoimmune skin diseases and restore skin health.

Portfolio Image

About Ahammune Biosciences

Ahammune Biosciences, based in Pune, India, is a biotech company focusing on therapeutic innovations for autoimmune skin diseases:

  • Core Innovation: Developing a new drug candidate for vitiligo (AB1001), which has completed Phase 1 trials with a first-in-class mechanism of action.

  • Market Potential: Global vitiligo market is estimated at $4.3B by 2027.

  • Intellectual Property: 3 patents filed, with 1 granted in India.

  • Clinical Efficacy: AB1001 gel is designed for topical application twice daily over five months, showing a safe profile for long-term use.

  • Research-Driven Leadership: Led by experts in dermatology and molecular biology, leveraging decades of research in skin biology.


Meet the Founders:

FUND

Fund I

INDUSTRY

BioTech

Dermatology and Autoimmune Therapeutics
Laptops

Naganand and Suri are not merely Ahammune's investors, they are our invaluable partners who work with us to translate our vision. Being entrepreneurs themselves, they really understand the challenges of a startup company and are always there to guide the founder with their tremendous experience.

Parul Ganju

Founder and CEO, Ahammune
image
OUR FOCUS AREAS

Where We Fuel Innovation and Sustainable Growth

We partner with visionary founders across these industries, bridging bold ideas with resources for real-world impact and lasting change.

Enterprise

Supercharging the Modern Enterprise
Laptops

Artificial Intelligence

Breaking Boundaries with Next-Gen Technologies
Laptops

BioTech

Pioneering Better Health Through Innovation
Laptops

DefenceTech

Advancing Security & Resilience for Tomorrow
Laptops

ClimateTech

Innovating for a Greener Tomorrow
Laptops
OUR BLOG

Stay Inspired with Our Latest Articles

Explore insights and stories that fuel startup innovation through our curated articles and expert perspectives.

  WHY WE INVEST

Why did we invest? — BluJ Aero

by Ideaspring Capital
Laptops
  Why we invest

Why did we invest? — Okulo Aerospace

by Ideaspring Capital
Laptops
  WHY WE INVEST

Why did we invest? — Kcat Enzymatic

by Ideaspring Capital
Laptops
GET IN TOUCH

Ready to Build the Future Together?

Let’s turn your bold ideas into transformative realities. with Ideaspring Capital to scale innovation, accelerate growth, and make a lasting impact in the world of technology.